| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.41 |
5e-19 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.39 |
3e-18 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.47 |
5e-17 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.35 |
1e-13 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
7e-12 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-08 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-07 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
6e-07 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-07 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.28 |
8e-07 |